Related Experiment Video
Updated: Aug 10, 2026
08:51
Human Egg Maturity Assessment and Its Clinical Application
Published on: August 19, 2019
[Prognosis for the development of Czech pharmaceutical services]
V Klemerová1, T Petrlík, J Kotlárová
1Katedra sociální a klinické farmacie Farmaceutické fakulty Univerzity Karlovy, Hradec Králové.
Summary
Czech pharmaceutical experts predict significant changes in pharmaceutical services, including widespread computerization and reduced product variety, by the early 2000s. The Delphi method proved effective for forecasting these future trends in pharmacy practice.
Area of Science:
- Pharmaceutical services
- Health policy
- Future studies
Context:
- The Czech Republic's pharmaceutical sector is undergoing potential transformations.
- Expert opinions are crucial for forecasting service evolution.
- The Delphi method is a recognized tool for expert consensus building.
Purpose:
- To forecast changes in the Czech pharmaceutical service using the Delphi method.
- To gather and analyze expert opinions on future pharmacy practices.
- To assess the suitability of the Delphi method for pharmaceutical service prognostication.
Summary:
- Czech pharmaceutical experts, surveyed via the Delphi method, anticipate major service changes by the new century.
- Key predicted innovations include rapid computer technology adoption and a narrowed pharmacy assortment.
- Experts foresee a potential decrease in extemporaneous preparations and the establishment of fixed consumer pharmaceutical prices.
Impact:
- Provides insights into the future direction of pharmaceutical services in the Czech Republic.
- Highlights expert consensus on key technological and operational shifts in pharmacies.
- Informs stakeholders about anticipated changes in pharmaceutical preparation and pricing models.
Related Concept Videos
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).